Quantcast

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Your information is NEVER sold to a third party. 

Pharma is poised to make billions from COVID-19 vaccine booster shots many aren’t okay with that

Advertisements
Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

COVID-19 vaccine boosters are coming and many who are already skeptical of a medical industry reaping profits from a national disaster have more reasons to question those at the top. While vaccines do work and have offered plentiful protections so far to the inoculated, it remains to be seen how much more good pharma will do with billions in profit from said boosters.

According to Newser, one section of Pharma (namely Pfizer) is expected to make upwards of $26B in sales from its vaccines and boosters whilst Moderna is expected to make upwards of $14B.

Moderna has no other reported product in the market outside of its vaccines and pending booster shots that it hopes to get endorsed by governments. In Britain, the government is expected to actually recommend the opposite Pfizer being the first choice Moderna being the second.


Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
See also  Alert: Broadway usher in NYC who worked two shows tests positive for the novel Coronavirus
By Guest Columns

Leave a Reply

Related Posts

No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.
Skip to content